+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Detox Product Market Size, Share & Trends Analysis Report By Product (Pharmaceuticals, Herbal and Cosmetics), By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 92 Pages
  • February 2024
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5943225
The Asia Pacific Detox Product Market would witness market growth of 5.6% CAGR during the forecast period (2023-2030).

Detox products primarily support the body's natural detoxification processes by eliminating toxins, impurities, and waste buildup from environmental pollutants, unhealthy dietary habits, and lifestyle factors. Many products are marketed as aids for weight loss and metabolism support. They may help individuals shed excess weight by promoting eliminating water weight, reducing bloating, and supporting healthy digestion.

Certain products contain ingredients that support digestive health, such as fiber, probiotics, and digestive enzymes. These products may help improve gastrointestinal function, alleviate bloating, gas, and discomfort, and promote regular bowel movements. The liver plays a crucial role in detoxification by metabolizing and eliminating toxins from the body. Detox products formulated with ingredients that support liver health, such as milk thistle, dandelion root, and turmeric, may help enhance liver function and support detoxification processes. Prebiotics, probiotics, digestive enzymes, and fiber-rich ingredients are key components of detox formulations designed to promote gut health, improve digestion, and support immune function.

The aging population in China presents opportunities for the market to address older consumers' evolving health and wellness needs. As per the findings of the State Council of the People's Republic of China, the proportion of Chinese citizens aged 60 or older in the overall population stands at 18.7 percent. This represents an increase of 5.44 percentage points compared to the data from the previous census conducted in 2010. Among the 264.02 million Chinese citizens aged 60 or older residing on the mainland, 190.64 million are 65 or older, representing 13.5% of the total population. Therefore, the prevalence of diabetes and the rising elderly population in the region propel the market's growth.

The China market dominated the Asia Pacific Detox Product Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $5,586.8 million by 2030. The Japan market is exhibiting a CAGR of 4.9% during (2023 - 2030). Additionally, The India market would experience a CAGR of 6.2% during (2023 - 2030).

Based on Product, the market is segmented into Pharmaceuticals, Herbal and Cosmetics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • Novartis AG
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Himalaya Global Holdings Ltd.
  • Mallinckrodt PLC
  • Daiichi Sankyo Company, Limited
  • Sun Pharmaceutical Industries Ltd.
  • Bioforce
  • Herbalife nutrition Ltd.
  • Amway Corporation

Market Report Segmentation

By Product
  • Pharmaceuticals
  • Herbal
  • Cosmetics
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Detox Product Market, by Product
1.4.2 Asia Pacific Detox Product Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Asia Pacific Detox Product Market by Product
4.1 Asia Pacific Pharmaceuticals Market by Country
4.2 Asia Pacific Herbal Market by Country
4.3 Asia Pacific Cosmetics Market by Country
Chapter 5. Asia Pacific Detox Product Market by Country
5.1 China Detox Product Market
5.1.1 China Detox Product Market by Product
5.2 Japan Detox Product Market
5.2.1 Japan Detox Product Market by Product
5.3 India Detox Product Market
5.3.1 India Detox Product Market by Product
5.4 South Korea Detox Product Market
5.4.1 South Korea Detox Product Market by Product
5.5 Singapore Detox Product Market
5.5.1 Singapore Detox Product Market by Product
5.6 Malaysia Detox Product Market
5.6.1 Malaysia Detox Product Market by Product
5.7 Rest of Asia Pacific Detox Product Market
5.7.1 Rest of Asia Pacific Detox Product Market by Product
Chapter 6. Company Profiles
6.1 Novartis AG
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 Pfizer, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional & Segmental Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Acquisition and Mergers:
6.2.5.3 Geographical Expansions:
6.2.6 SWOT Analysis
6.3 Teva Pharmaceutical Industries Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 SWOT Analysis
6.4 Himalaya Global Holdings Ltd.
6.4.1 Company Overview
6.5 Mallinckrodt PLC
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 SWOT Analysis
6.6 Daiichi Sankyo Company, Limited
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Product and Services and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 SWOT Analysis
6.7 Sun Pharmaceutical Industries Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expenses
6.7.5 SWOT Analysis
6.8 Bioforce
6.8.1 Company Overview
6.8.2 SWOT Analysis
6.9 Herbalife Nutrition Ltd.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 SWOT Analysis
6.10. Amway Corporation
6.10.1 Company Overview
6.10.2 SWOT Analysis

Companies Mentioned

  • Novartis AG
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Himalaya Global Holdings Ltd.
  • Mallinckrodt PLC
  • Daiichi Sankyo Company, Limited
  • Sun Pharmaceutical Industries Ltd.
  • Bioforce
  • Herbalife nutrition Ltd.
  • Amway Corporation

Methodology

Loading
LOADING...